breastfeeding tirzepatide during Early evidence by InfantRisk Center suggests doesn't meaningfully enter breast milk, the Zepbound and Breastfeeding: Safety &

Diabetologia (2004) 47(7):117587

It is reproduced here from the product record itself rather than retyped, which means it cannot drift away from what the attribute table further up the page says

Fun fact: Matrixyl was originally developed by French company Sederma and Procter & Gamble

Compounded tirzepatide differs from FDA-approved Mounjaro and Zepbound in several important ways

Patients should not flush tablets down the toilet or pour them into drains unless specifically instructed to do so, as this can contribute to pharmaceutical contamination of water supplies

This week on the You Are Not Broken podcast episode #329, I sat down with the powerhouse that is Dr